The history of acute promyelocytic leukaemia

British Journal of Haematology

Volumn 122, Issue 4, 2003, Pages 539-553

  Degos, Laurent ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Acute leukaemia; Acute promyelocytic leukaemia; All trans retinoic acid; Arsenic; Differentiation therapy

Indexed keywords

AILING 1; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ARSENIC; CYTARABINE; DAUNORUBICIN; ETRETINATE; HEPARIN; HISTONE DEACETYLASE INHIBITOR; HOMOHARRINGTONINE; IMATINIB; INTERFERON; ISOTRETINOIN; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; CLINICAL FEATURE; CLINICAL TRIAL; HAIRY CELL LEUKEMIA; HUMAN; LIVER FAILURE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; THROMBOCYTE TRANSFUSION;

ANTINEOPLASTIC AGENTS; ARSENIC; CHROMOSOME ABERRATIONS; HISTORY, 20TH CENTURY; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; TRETINOIN;

EID: 0042161893     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04460.x     Document Type: Review

References (114)

1. Agadir, A., Cornic, M., Lefebvre, P., Gourmel, B., Jerome, M., Degos, L., Fenaux, P. & Chomienne, C. (1995) All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukaemia: intracellular concentrations and biologic response relationship. Journal of Clinical Oncology, 13, 2517-2523.
2. Arnould, C., Philippe, C., Bourdon, V., Gregoire, M.J., Bergen R. & Jonveaux, P. (1999) The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. Human Molecular Genetics, 8, 1741-1749.
3. Avvisati, G., ten Cate, J.W., Sturk, A., Lamping, R., Petti, M.C. & Mandelli, F. (1988) Acquired alpha2 antiplasmin deficiency in acute promyelocytic leukaemia. British Journal of Haematology, 70, 43-48.
4. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D., Gralnick, M. & Sultan, C. (1976) Proposals for the classification of the acute leukaemias. British Journal of Haematology, 33, 451-458.
5. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D., Gralnick, M. & Sultan, C. (1980) A variant form of hypergranular promyelocytic leukaemia. British Journal of Haematology, 44, 169-170.
6. Bennett, M., Parker, A.C. & Ludlam, C.A. (1976) Platelet and fibrinogen survival in acute promyelocytic leukaemia. British Journal of Medicine, 2, 565.
7. Bernard, J., Mathe, G., Boulay, J., Ceoard, B. & Chome, J. (1959) Acute promyelocytic leukaemia: a study made on 20 cases. Schweiz Medical Wochenschrifte, 89, 604-608.
8. Bernard, J., Weil, M., Boiron, M., Jacquillat, C., Flandrin, G. & Gemon, M.F. (1973) Acute promyelocytic leukaemia. Results of treatment with daunorubicin. Blood, 41, 489-496.
9. Biondi, A., Rambaldi, A., Pandolfi, P.P., Rossi, V., Giudici, G., Alcalay, M., Lo Coco, F., Diverio, D., Pogliani, E.M., Lanzi, E.M., Mandelli, F., Masera, G., Barbui, T. & Pelicci, P.G. (1992) Molecular monitoring of the myl/retinoic acid receptor alpha fusion gene in APL by polymerase chain reaction. Blood, 80, 492-497.
10. Borrow, J., Goddard, A., Sheer, D. & Solomon, E. (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science, 249, 1577-1580.
11. Brasch, K. & Ochs, R.L. (1992) Nuclear bodies (NBs): a newly 'rediscovered organelle'. Experimental Cell Research, 202, 211-223.
12. Breitman, T.R., Collins, A.J. & Keene, B.R. (1981) Terminal differentiation of human promyelocytic leukaemia cells in primary culture in response to retinoic acid. Blood, 57, 1000-1008.
13. Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P.G., Atwater, S. & Bishop, J.M. (1997) A PML RAR alpha transgene initiates murine acute promyelocytic leukaemia. Proceedings of the National Academy of Sciences of the United States of America, 94, 2551-2556.
14. Caen, J., Mathe, G., Xuan Chat, L. & Bernard, J. (1957) Etude de la fibrinolyse au cours des hémopathies malignes. Transcripts of the Sixth Congress of the European Society of Hematology. Copenhagen. 502-506.
15. Caen, J., Larrieu, M.H. & Bernard, J. (1959) Afibrinémies acquises. Review of French Clinical Biology, 4, 363-366.
16. Cassinat, B., Chevret, S., Zassadowski, F., Balitrand, N., Guillemot, I., Menot, M.L., Degos, L., Fenaux, P. & Chomienne, C. (2001) In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukaemia blasts: a novel indicator of poor patient outcome, Blood, 9, 2862-2864.
17. Castaigne, S., Chomienne, C., Daniel, M.T., Berger, R., Fenaux, P. & Degos, L. (1990) All-trans retinoic acid as a differentiating therapy for acute promyelocytic leukaemias. I. Clinical results. Blood, 76, 1704-1709.
18. Castaigne, S., Balitrand, N., de The. H., Dejean, A., Degos, L. & Chomienne, C. (1992) A PML/RAR alpha fusion transcript is constantly detected by RNA based polymerase chain reaction in acute promyelocytic leukaemia. Blood, 79, 3110-3118.
19. Chelbi-Alix, M. & de Thé, H. (eds) (2001) Ten years of molecular APL: from RARα to PML nuclear antibodies. Oncogene, 20, 7135-7291.
20. Chen, G.Q., Zhu, J., Shi, X.G., Hi, J.H., Zhong, H.J., Si, G.Y. & Jin. X.L. (1996) In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As203) in the treatment of acute promyelocytic leukaemia. As203 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood, 88, 1052-1061.
21. Chen, X.J., Xue, Y.Q., Zhang, R., Tao, R.F., Xia, X.M., Li, C., Wang, W., Zu, W.Y., Yao, X.Z. & Ling, B.J. (1991) A clinical and experimental study on all trans retinoic acid treated acute promyelocytic leukaemia patients. Blood, 78, 1413-1419.
22. Chen, Z.C., Brand, N.J., Chen, A., Chen, S.J., Tong, S.H., Wang, Z.Y., Waxman, S. & Zelent, A. (1993) Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO Journal, 12, 1161-1167.
23. Chen, Z., Chen, C.G., Shen, Z.X., Chen, S.H. & Wang, Z.Y. (2001) Treatment of acute promyelocytic leukaemia with arsenic compounds. In vitro and in vivo studies. Seminars in Hematology, 38, 26-36.
24. Chomienne, C., Balitrand, N., Degos, L. & Abita, J.P. (1986a) 1-B-D arabinofuranosyl cytosine and all-trans retinoic acid in combination accelerates and increases monocyte differentiation of myeloid leukemic cells. Leukemia Research, 6, 631-636.
25. Chomienne, C., Balitrand, N. & Abita, J.P. (1986b) Inefficacy of the synthetic aromatic retinoid etretinate and of its free acid on the in vitro differentiation of leukemic cells. Leukemia Research, 10, 1079-1081.
26. Chomienne, C., Ballerini, P., Balitrand, N., Amar, M., Bernard, J.F., Boivin, P., Daniel, M.T., Berger, R., Castaigne, S. & Degos, L. (1989) Retinoic acid therapy for promyelocytic leukaemias, Lancet, i, 746-747.
27. Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M.T., Fenaux, P., Castaigne, S. & Degos, L. (1990a) Differentiation of acute promyelocytic cells by all-trans retinoic acid. II. In vitro studies: structure-function relationship, Blood, 76, 1710-1717.
28. Chomienne, C., Ballerini, P., Huang, M.E., Castaigne, S., Fenaux, P., Tiollais, P., Dejean, A., Degos, L. & de Thé, H. (1990b) The retinoic acid receptor alpha gene is rearranged in retinoic acid sensitive promyelocytic leukaemias. Leukemia, 4, 802-807.
29. Collins, S.J., Robertson, K.A. & Mueller, L. (1990) Retinoic acid induced granulocytic differentiation of HL-60 myeloid leukaemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Molecular Cell Biology, 10, 2154-2163.
30. Cooperberg, A.A. & Neiman, G.M.A. (1955) Fibrinogenpenia and fibrinolysis in acute myelogenous leukemia. Annals of International Medicine, 42, 707-711.
31. Cornic, M., Delva, L., Guidez, F., Balitrand, N., Degos, L. & Chomienne, C. (1992) Induction of retinoic acid binding protein in normal and malignant human myeloid cells by retinoic acid in AML3 patients. Cancer Research, 52, 3329-3334.
32. Dalton, Jr. W.T., Ahearn, M.J., McCredie, K.B., Freireich, E.J., Stass, S.A. & Trujillo, J.M. (1988) HL-60 cell line was derived from a patient with FAM-M2 and not FAB-M3, Blood, 71, 242-247.
33. Daniel, M.T., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M.C., Degos, L., Chomienne, C. & de The, H. (1993) PML protein expression in haematopoietic and APL cells. Blood, 82, 1858-1867.
34. Degos, L. (1994) Is acute promyelocytic leukaemia a curable disease? Treatment strategy for long term survival. Leukemia, 8, 56s-58s.
35. Degos, L., Castaigne, S., Chomienne, C., Huang, M.E., Tilly, H., Bordessoule, D., Micléa, J.M., Thomas, G., Najean, Y., Abita, J. & Wang, Z.Y. (1988) Therapeutic trials of acute myeloid leukemias and myelodysplastic syndromes by LD ARA-C and treatment of acute promyelocytic leukemia by retinoic acid. In: The Status of Differentiation Therapy of Cancer (ed. by S. Waxman, G.B. Rossi, F. Takaku). 45. 361-373. Serono Symposium Publications from Raven Press.
36. Degos, L., Chomienne, C., Daniel, M.T., Berger, R., Dombret, H., Fenaux, P. & Castaigne, S. (1990) Treatment of first relapse in acute promyelocytic leukemia with all trans retinoic acid. Lancet, 2, 1440-1441.
37. Degos, L., Dombret, H., Chomienne, C., Daniel, M.T., Miclea, J.M., Chastang, C., Castaigne, S. & Fenaux, P. (1995) All trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia, Blood, 85, 2643-2653.
38. Delva, L., Bastie, J.N., Rochette-Egly, C., Kraiba, R., Balitrand, N., Despouy, G., Chambon, P. & Chomienne, C. (1999) Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Molecular Cell Biology, 10, 7158-7167.
39. Diverio, D., Rossi, V., Avvisati, G., De Santis, S., Pistilli, A., Pane, F., Saglio, G., Martinelli, G., Petti, M.C., Santoro, A., Pellici, P.G., Mandelli, F., Biondi, A. & Lo Coco, F. (1998) Early detection of relapse by prospective RT-PCR analysis of the PML-RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter AIDA trial, Blood, 92, 784-789.
40. Dombret, H., Scrobohaci, M.L., Ghorra, P., Zini, J.M., Daniel, M.T., Castaigne, S. & Degos, L. (1993) Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment, Leukemia, 7, 2-9.
41. Dombret, H., Scrobohaci, M.L., Daniel, M., Miclea, J.M., Castaigne, S., Chomienne, C., Fenaux, P. & Degos, L. (1995) In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy, Leukemia, 9, 19-24.
42. Dubois, C., Schlageter, M.H., de Gentile, A., Balitrand, N., Toubert, M.E., Krawice, I., Fenaux, P., Castaigne, S., Najean, Y. & Degos, L. (1994) Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic leukemia, Leukemia, 8, 1750-1757.
43. Fagioli, M., Alcalay, M., Pandolfi, P.P., Venturini, L., Mencarelli, A., Simeone, A., Acampora, D., Grignani, F. & Pelicci, P.G. (1992) Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene, 7, 1083-1091.
44. Fenaux, P., Castaigne, S., Dombret, H., Archimbaud, E., Duarte, M., Morel, P., Lamy, T., Tilly, H., Guerci, A., Maloisel, F., Bordessoule, D., Sadoun, A., Tiberthein, P., Fegueux, N., Daniel, M.T., Chomienne, C. & Degos, L. (1992) All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood, 80, 2176-2181.
45. Fenaux, P., Le Deley, M.C., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M.T., Bowen, D., Huebner, G., Bauters, F., Fegueux, N., Fey, M., Sanz, M., Lowenberg, B., Maloisel, F., Auzanneau, G., Sadoun, A., Gardin, C., Bastion, Y., Ganser, A., Jacky, E., Dombret, H., Chastang, C., Degos, L. & the European APL 91 Group (1993) Effect of all trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood, 82, 3241-3249.
46. Fenaux, P., Wattel, E., Archimbaud, E., Sanz, M., Guerci, A., Link, H., Fegueux, N., Fey, M., Castaigne, S., Degos, L. & the French APL Group (1994) Prolonged follow up confirms that all trans retinoic acid (ATRA) followed by chemotherapy reduces the risk of relapses in newly diagnosed acute promyelocytic leukemia (APL). Blood, 84, 666-667.
47. Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.J., Gardin, C., Cony Makhoul, P., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., San Miguel, J., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C. & Degos, L. for the European APL Group (1999) A randomized comparison of all trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood, 94, 1192-1200.
48. Fibach, E., Hayashi, M. & Sachs, L. (1973) Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes. Proceedings of the National Academy of Sciences of the United States of America, 70, 343-346.
49. Frankel, S.R., Eardley, A., Lauwers, G., Weiss, M. & Warrell, R.P. (1992) The 'retinoic acid syndrome' in acute promyelocytic leukemia. Annals of Internal Medicine, 117, 292-296.
50. Ginsburg, H. & Sachs, L. (1963) Formation of pure suspensions of mast cells in tissue culture by differentiation of lymphoid cells from the mouse thymus. Journal of the National Cancer Institute, 31, 1-40.
51. Golomb, H.M., Rowley, J., Vardiman, J., Baron, J., Locker, G. & Krasnow, S. (1976) Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia? Archives of Internal Medicine, 136, 293-396.
52. Gootwine, E., Webb, C.G. & Sachs, L. (1982) Participation of myeloid leukaemic cells injected into embryos in haematopoietic differentiation in adult mice. Nature, 299, 63-65.
53. Grignani, F., de Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F.F., Zamir, I., Seiser, C., Lazar, M.A., Minucci, S. & Pelicci, P.G. (1998) Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature, 391, 815-818.
54. Grisolano, H.J.L., Wesselschmidt, R.L., Pelicci, P.G. & Ley, T.J. (1997) Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood, 89, 376-387.
55. He, L.Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A. & Pandolfi, P.P. (1998) Distinct interactions of PML-RAR alpha and PLZF-RAR alpha with co-repressors determine differential responses to RA in APL. Nature Genetics. 18, 126-135.
56. Head, D., Kopecky, K.J., Weick, J., Files, H.C., Ryan, D., Foucar, K., Montiel, M., Bickers, H., Fishleder, A., Miller, M., Spier, C., Hanson, C., Mitter, M., Braziel, R., Mills, G., Welborn, J., Williams, W., Hewlett, J., Willman, C. & Appelbaum, F.R. (1995) Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia. Blood, 86, 1717-1728.
57. Hillestad, L.K. (1957) Acute promyelocytic leukemia. Acta Medical Scandinavica, 159, 189-194.
58. Hong, S.H., David, G., Wong, C.W., Dejean, A. & Privalsky, M.L. (1997) SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 94, 9028-9033.
59. Housset, M., Daniel, M.T. & Degos, L. (1982) Small doses of ARA-C in the treatment of acute myeloid leukemia: differentiation of myeloid leukemic cells? British Journal of Hematology, 51, 125-129.
60. Huang, M., Yu-Chen, Y., Shu-Rong, C., Jin-Ren, C., Lu, J.X., Zhoa, L., Gu, L.J. & Wang, Z.Y. (1988) Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
61. Jansen, J.H., de Ridder, M.C., Geertsma, W.M., Eperlink, C.A.J., Van Lom, K., Smit, E.H.E., Slater, R., Reigden, B., de Greef, G.E., Sonneveld, P. & Lowenberg, B. (1999) Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all trans retinoic acid and granulocyte colony-stimulating factor. Blood, 94, 39-45.
62. Jensen, K., Shiels, C. & Freemont, P.S. (2001) PML protein isoforms and the RBCC/TRIM motif. Oncogene, 20, 7223-7233.
63. Kakizuka, A., Miller, Jr. W.H., Umesono, K., Warrell, R.P., Frankel, S.R., Murty, V.S., Dmitrovsky, E. & Evans, R.M. (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor. PML, Cell, 66, 663-674.
64. Kanamaru, A., Takemoto, Y., Tanimoto, M., Murakami, H., Asou, N., Kobayashi, R., Ohmoto, E., Sakamaki, H. & Tsubaki, K. (1995) All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood, 85, 1202-1206.
65. Kantarjian, H., Keating, M. & Walters, R. (1986) Acute promyelocytic leukemia. MD Anderson Hospital Experience. American Journal of Medicine, 80, 789-797.
66. Koken, M.H.M., Puvion-Dutilleul, F., Guillemin, M.C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C., Degos, L., Puvion, E. & de Thé, H. (1994) The t(15;17) translocation alters a nuclear body in an RA-reversible fashion. EMBO Journal, 13, 1073-1083.
67. Lallemand-Breitenbach, V., Guillemin, M.C., Janin, A., Daniel, M.T., Degos, L., Kogan, S.C., Bishop, J.M. & de The, H. (1999) Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. Journal of Experimental Medicine, 189, 1043-1052.
68. Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honore, N., Doubeikovsky, A., Duprez, E., Pandolfi, P.P., Puvion, E., Freemont, P. & de The, H. (2001) Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment and AS2O3 induced PML or PML/retinoic acid receptor alpha degradation. Journal of Experimental Medicine, 193, 1361-1372.
69. Lanotte, M., Martin-Thouvenin, V., Najman, S., Ballerini, P., Valensi, F. & Berger, R. (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood, 77, 1080-1086.
70. Larson, R.A., Kondo, K., Vardiman, J.W., Butler, A.E., Golomb, H.M. & Rowley, J.D. (1984) Evidence for a 15:17 translocation in every patient with acute promyelocytic leukemia. American Journal of Medicine, 76, 827-841.
71. Lin, R.J., Nagy, L., Inoue, S., Shao, W.L., Miller, W.H. & Evans, R.M. (1998) Role of the histone deacetylase complex in acyte promyelocytic leukaemia. Nature, 391, 811-814.
72. Lo Coco, F., Diverio, D., Pandolfi, P.P., Biondi, A., Rossi, V., Avvisati, G., Rambaldi, A., Arcese, W., Petti, M.C., Meioni, G., Mandelli, F., Grignani, F., Masera, G., Barbui, T. & Pelicci, P.G. (1992) Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet, 340, 1437-1438.
73. Longo, L., Pandolfi, P., Biondi, A., Rambaldi, A., Mencarelli, A., Lo Coco, F., Diverio, D., Pegoraro, L., Avanzi, G., Tabilio, A., Zangrilli, D., Alcalay, M., Donti, E., Grignard, F. & Pelicci, P. (1990) Rearrangement and aberrant expression of the retinoic acid receptor α gene in acute promyelocytic leukemia. Journal of Experimental Medicine. 172, 1571-1575.
74. Lufkin, T., Lohnes, D., Mark, M., Dierich, A., Gorry, P., Gaub, M.P., Le Meur, M. & Chambon, P. (1993) High postnatal lethality and testis denegeration in retinoic acid receptor alpha mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 90, 7225-7229.
75. McKenna, R.W., Parkin, J., Bloomfield, C.D., Sundberg, R.D. & Brunning, R.D. (1982) Acute promyelocytic leukemia: a study of 39 cases with identification of a hyperbasophilic microgranular variant. British Journal of Haematology, 50, 201-214.
76. Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Cerri, R., Falda, M., Fioritoni, G., Leoni, F., Liso, V., Petti, M.C., Rodeghiero, F., Saglio, G., Vegna, M.L., Visani, G., Vehn, U., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A. & Lo Coco, F. (1997) Molecular remission in PML-RAR alpha positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (IDA) therapy. Blood, 90, 1014-1021.
77. Mao, M., Yu, M., Tong, J.H., Ye, J., Zhu, H., Huang, Q.H., Fu, G., Yu, L., Zhao, S.Y., Waxman, S., Lanotte, M., Wang, Z.Y., Tan, J.Z., Chan, S.H. & Chen, Z. (1996) RIG-E, a human homolog of the murine Ly-6 family is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. Proceedings of the National Academy of Sciences of the United States of America, 93, 5910-5914.
78. Marty, M., Ganem, G., Fisher, J., Flandrin, G., Berger, R., Schaison, G., Degos, L. & Boiron, M. (1984) Leucémie aiguë promyelocytaire: étude rétrospective de 119 malades traités par daunorubicine. Nouvelle Review d'Hematologie Francaise, 26, 371-378.
79. Mattei, M.G., Petkovich, M., Mattei, J.F., Brand, N. & Chambon, P. (1988) Mapping of the human retinoic acid receptor to the q21 band of chromosome 17. Human Genetics, 80, 186-188.
80. Menell, J.S., Cesarman, G.M., Jocovina, A., McLaughlin, M.A., Lev, E.A. & Hajjar, K.A. (1999) Annexin II and bleeding in acute promyelocytic leukemia. New England Journal of Medicine, 340, 994-1004.
81. Muindi, J., Frankel, S.R., Miller, W.H., Jakubowski, A., Scheinberg, D.A., Young, C.W., Dimitrovsky, E. & Warrell, R.P. (1992) Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid 'resistance' in patients with acute promyelocytic leukemia. Blood, 79, 299-303.
82. Nagy, L., Kao, H.Y., Chakravarti, D., Lin, R.J., Hassig, C.A., Ayer, D.E., Schreiber, L.S. & Evans, R.M. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSIN3A, and histone deacetylase. Cell, 89, 373-380.
83. Niu, C., Yan, H., Yu, T., Sun, H.P., Liu, J.X., Li, X.S., Wu, W., Zhang, F.Q., Chen, Y., Zhou, L., Li, J.M., Zeng, X.Y., Yang, R.R., Yuan, M.M., Ren, M.Y., Gu, F.Y., Cao, Q., Gu, B.W., Su, X.Y., Chen, G.Q., Xiong, S.M., Zhang, T.D., Waxman, S., Wang, Z.Y., Chen, Z., Hu, H., Shen, Z.X. & Chen, S.J. (1999) Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up and molecular monitoring in 11 newly diagnosed and 47 relapsed APL patients. Blood, 94, 3315-3324.
84. O'Dwyer, M.E., Mauro, M.J., Jurilik, G., Mori, M., Balleisen, S., Olson, S., Magenis, E., Capdeville, R. & Druker, B.J. (2002) The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML. Blood, 100, 1628-1633.
85. Padua, R.A., Le Pogam, C., Larghero, H., Robin, M., Schlageter, M.H., Muszlak, S., Fric, J., West, R., Roussselot, P., Phan, T.H., Mudder, L., Teisserenc, H., Carpentier, A.F., Kogan, S., Stevenson, F., Degos, L., Pla, M., Bishop, J.M., Charron, D. & Chomienne, C. (2002) Fusion-oncogene DNA based vaccine induces protective immunity: example of a targeted therapy in an acute promyelocytic leukemia animal model. Blood, 100 supplement, a741.
86. Paran, M., Sachs, L., Barak, Y, & Resnitzky, P. (1970) In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proceedings of the National Academy of Sciences of the United States of America, 67, 1542-1549.
87. Petkovich, M., Brand, N.J., Krust, A. & Chambon, P. (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature, 330, 444-450.
88. Piazza, F., Gurrieri, C. & Pandolfl, P.P. (2001) The theory of APL. Oncogene, 20, 7216-7222.
89. Pisciotta, A.V. & Schultz, J.E. (1955) Fibrinolytic purpura in acute leukaemia. American Journal of Medicine, 19, 824-828.
90. Poirier, O., Chomienne, C., Castaigne, S., Degos, L., Abita. J.P. & Najean, Y. (1986) Pharmacokinetic data on very low dose cytarabine. Lancet, i, 1436-1437.
91. Redner, R.L., Rush, E.A., Faas, S., Ruder, W.A. & Corey, S.J. (1996) The t(5:17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinic acid receptor fusion. Blood, 87, 882-886.
92. Risak, E. (1935) Die fibrinopenie. Zeitschrift Fur Klinische Medizin, 128, 605-629.
93. Rodighiero, F., Awisati, G., Castaman, G., Barbui, T. & Mandelli, F. (1990) Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood, 11, 2112-2117.
94. Rousselot, P., Hardas, B., Patel, A., Guidez, F., Gaken, J., Castaigne, S., Dejean, A., de The, H., Degos, L., Farzaneh, F. & Chomienne, C. (1994) The PML/RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid induced differentiation and mediated transactivation in human myeloid ceils. Oncogene, 9, 545-551.
95. Rowley, J.D., Golomb, H.M. & Dougherty, C. (1977) The 15/17 translocation: a consistent chromosomal change in acute promyelocytic leukaemia. Lancet, i, 549-550.
96. Schoch, C., Haase, D., Haferlach, T., Freund, M., Link, H., Lengfelder, E., Loffler, H., Buchner, T. & Fonatsch, C. (1996) Incidence and implication of additional chromosome aberrations in acute promyelocytic leukemia with translocation t(15;17) (q22;q21). A report of 50 patients. British Journal of Haematology, 94, 493-500.
97. Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwah, S., Calleja, E., Dardashti, L.J., Corso, D., De Blasio, A., Gabrilove, H., Scheinberg, D.A., Pandolfi, P.P. & Warrell, R.P. (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New England Journal of Medicine, 339, 1341-1348.
98. Stormorken, H. (1956) Fibrinolytic purpura associated with myelogenous leukaemia case. Tidsskrift for Den Norske Laegeforening, 76, 754-756.
99. Sun, H.D., Ma, L., Hu, X.C. & Zhang, T.D. (1992) Treatment of acute promyelocytic leukemic by Al-1 therapy. Chinese Journal of the Integration of Traditional and Western Medicine, 12, 170-172.
100. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernick, P.H. (1997) All trans retinoic acid in acute promyelocytic leukemia. New England Journal of Medicine, 337, 1021-1028.
101. de Thé, G., Riviere, M. & Bernhard, W. (1960) Examen au microscope électronique de la tumeur VX2 du lapin domestique derivée du papillome de Shope. Bulletin of the Cancer, 47, 570-584.
102. de Thé, G., Marchio, A., Tiollais, P. & Dejean, A. (1989) Differential expression and ligand regulation of the retinic acid receptor α and β genes. EMBO Journal, 8, 429-433.
103. de Thé, H., Chomienne, C., Lanotte, M., Degos, L. & Dejean, A. (1990) The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature, 347, 558-561.
104. de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. & Dejean, A. (1991) The myl RAR alpha fusion mRNA generated by the t(15;17) translocation in APL encodes a functionally altered retinoic acid receptor. Cell, 66, 675-684.
105. Tilly, H., Castaigne, S., Bordessoule, D., Sigaux, F., Daniel, M.T., Monconduit, M. & Degos, L. (1985) Low dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients. Cancer, 55, 1633-1636.
106. Tsai, S., Bartelmez, S., Heyman, R., Damm, K., Evans, R. & Collins, S.J. (1993) A mutated retinoic acid receptor a exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes and Development, 6, 2258-2269.
107. Wang, Z.Y., Sun, G.L., Shen, Z.X., Chen, S.J. & Chen, Z. (1999) Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application. Chinese Medical Journal, 112, 963-967.
108. Warrell, R.P., Frankel, S.R., Miller, W.H., Scheinberg, D.A., Itri, L., Hittelman, W.N., Vyas, R., Andreeff, M., Tafuri, A., Jabukowski, A., Gabrilove, J., Gordon, M.S. & Dmitrovsky, E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all trans retinoic acid). New England Journal of Medicine, 324, 1385-1393.
109. Warrell, R.P., Maslak, P., Eardley, A., Heller, G., Miller, W.H. & Frankel, S.R. (1994) Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia, 8, 926-933.
110. Wells, R.A., Catzavelos, C. & Kamel-Reid, S. (1997) Fusion of retinoic acid alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nature Genetics, 17, 109-113.
111. Wiernik, P.H. (1990) Acute promyelocytic leukemia: another pseudoleukemia? Blood, 76, 1675-1677.
112. Zang, D.T., Chen, G.Q., Wang, Z.G., Wang, Z.Y., Chen, S.J. & Chen, Z. (2001) Arsenic trioxide, a therapeutic agent for APL. Oncogene, 20, 7146-7153.
113. Zhu, J., Koken, M.H., Quignon, F., Chelbi-Alix, M., Degos, L., Wang, Z.Y., Chen, Z. & de The, H. (1997) Arsenic induced PML targeting onto nuclear bodies. Implications for the treatment of APL. Proceedings of the National Academy of Sciences of the United States of America, 94, 3978-3983.
114. Zhu, J., Guo, W.M., Yao, Y.Y., Zhao, W.L., Pan, L., Cai, X., Ju, B., Sun, G.L., Wang, H.L., Chen, S.J., Chen, G.Q., Caen, H., Chen, Z. & Wang, Z.Y. (1999) Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia, 13, 1062-1070.